Psagot Value Holdings’s Redhill Biopharma RDHL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-192
Closed -$1.4M 496
2021
Q1
$1.4M Buy
+192
New +$1.61M 0.03% 175
2020
Q2
Hold
0
-$2K 402
2020
Q1
Hold
0
371
2019
Q4
Sell
-1
Closed -$6.39K 425
2019
Q3
$4K Hold
1
﹤0.01% 387
2019
Q2
$6K Sell
1
-5
-83% -$38.5K ﹤0.01% 390
2019
Q1
$52K Hold
6
﹤0.01% 350
2018
Q4
$35K Hold
6
﹤0.01% 354
2018
Q3
$53K Buy
6
+5
+500% +$40.7K ﹤0.01% 293
2018
Q2
$9K Hold
1
﹤0.01% 315
2018
Q1
$4K Hold
1
﹤0.01% 327
2017
Q4
$4K Sell
1
-3
-75% -$20.2K ﹤0.01% 290
2017
Q3
$38K Buy
4
+3
+300% +$26.7K ﹤0.01% 274
2017
Q2
$11K Sell
1
-44
-98% -$423K ﹤0.01% 290
2017
Q1
$435K Buy
45
+36
+400% +$360K 0.02% 189
2016
Q4
$93K Buy
9
+5
+125% +$59.9K ﹤0.01% 237
2016
Q3
$51K Sell
4
-1
-20% -$14K ﹤0.01% 264
2016
Q2
$51K Sell
5
-1
-17% -$11.6K ﹤0.01% 254
2016
Q1
$69K Sell
6
-1
-14% -$10.5K ﹤0.01% 291
2015
Q4
$91K Sell
7
-1
-13% -$12.4K ﹤0.01% 294
2015
Q3
$106K Buy
8
+2
+33% +$29.6K ﹤0.01% 279
2015
Q2
$113K Buy
+6
New +$95.3K ﹤0.01% 294

Other funds holding RDHL

Psagot Value Holdings's RDHL Position: Q2 2021 in Review

Psagot Value Holdings sold out of Redhill Biopharma (RDHL) in Q2 2021, closing a stake of 192 shares — an estimated $1.4M sold.

Psagot Value Holdings first reported a position in RDHL in Q2 2015 and held it in 19 quarters. The position peaked at $1.4M in Q1 2021. 48 funds tracked by Wall St. Rank hold RDHL as of Q2 2021.

  • Psagot Value Holdings reported no remaining Redhill Biopharma position as of Q2 2021 after selling out during the quarter.
  • Psagot Value Holdings sold 192 Redhill Biopharma shares in Q2 2021, an estimated $1.4M.
  • Psagot Value Holdings first reported a position in Redhill Biopharma in Q2 2015 and held it in 19 quarters.
  • Psagot Value Holdings's Redhill Biopharma position peaked at $1.4M in Q1 2021.
  • 48 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2021.

Based on Psagot Value Holdings's 13F filing for Q2 2021, filed 11 Aug 2021.